Exosome Banking with CryoMaxx™ Processing™
Isolate and preserve your baby’s cord blood exosomes with CryoMaxx™ Processing and unlock their potential usage in clinical trials and future treatments.
What Are Exosomes?
Exosomes are tiny, extracellular vesicles that act as messengers by shuttling cellular components to other cells. They initiate cell-to-cell communication.
Exosomes are 30-150 nanometers in diameter. They are filled with a rich variety of proteins, RNA, DNA, and lipids. The composition (messages) of the exosome depends strongly on the type of cell the exosome originates from.
Why Should You Bank Your Baby’s Exosomes?
Decades of research have yielded evidence for the role of exosomes in intercellular communication. In fact, pre-clinical research has shown that exosomes may regulate immune responses, wound healing, and cell growth and development.
Today, there are currently no FDA-approved treatments, but researchers and scientists are studying these tiny vesicles for more than 100 clinical trials researching numerous applications for exosomes.
Americord’s CryoMaxx™ Exosome Processing
Americord’s CryoMaxx™ Exosome Processing unlocks the future potential of your baby’s cord blood exosomes.
The process uses a minimal manipulation process that enables lab technicians to isolate and extract exosomes from the cord blood. The exosomes are then cryopreserved, which ensures the potential for clinical research or future treatments.
Americord acknowledges that exosomes are not FDA-approved for use in treatments or products. Americord does not claim exosomes have any current therapeutic benefit. The client understands that they bank their child’s exosomes for use in clinical trials and research which may provide utility in the future. Exosome banking is not available to California residents.
Exosomes are nano-sized sacs ffilled with a rich variety of proteins, RNA, DNA, and lipids.
Exosomes are isolated and concentrated from the plasma portion of the cord blood using our proprietary CryoMaxx™ Processing.
No, there are no FDA-approved treatments using exosomes. However, there are hundreds of active clinical trials researching various applications for exosomes. You can view the full clinical trial list here.
Exosomes are not cells or living organisms. They cannot be expanded.
There are no FDA-approved exosome treatments or products. Any marketing of exosome products as biologic drugs intended for human use is illegal. However, there are numerous FDA-monitored clinical trials investigating the potential use of exosomes as a therapeutic treatment. Americord offers exosme banking for potential use in clinical research.
No, at the time Americord’s exosome banking is not available for California residents due to legal restrictions.